Patent details

EP2970441 Title: AGLYCOSYLATED Fc-CONTAINING POLYPEPTIDES

Basic Information

Publication number:
EP2970441
PCT Application Number:
US2014028913
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP147695415
PCT Publication Number:
WO2014153063
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
AGLYCOSYLATED Fc-CONTAINING POLYPEPTIDES
French Title of Invention:
POLYPEPTIDES CONTENANT FC AGLYCOSYLÉS
German Title of Invention:
POLYPEPTIDE MIT AGLYCOSYLIERTEM FC
SPC Number:

Dates

Filing date:
14/03/2014
Grant date:
06/03/2019
EP Publication Date:
20/01/2016
PCT Publication Date:
25/09/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/03/2019
EP B1 Publication Date:
06/03/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
14/03/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
27/02/2019
 
 

Name:
Amgen Inc.
Address:
One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
20/03/2019
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
KANNAN, Gunasekaran
Address:
United States (US)

Priority

Priority Number:
201361784669 P
Priority Date:
14/03/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/20; C07K 14/55; C07K 16/00;

Publication

European Patent Bulletin

Issue number:
201910
Publication date:
06/03/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/03/2026
Annual Fee Number:
13
Annual Fee Amount:
180 Euro
Expected Payer:
Last Annual Fee Payment Date:
18/02/2025
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
165 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages
20/03/2019 Power Of Attorney 1
01/04/2019 Outgoing Correspondence 1